Telix Pharmaceuticals Ltd reported AUD344.11M in Ordinary Share Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Cochlear COH:AU AUD 1.28B 0
Integral Diagnostics Ltd IDX:AU AUD 322.54M 88.01M
Mayne Pharma MYX:AU AUD 1.24B 0
Opthea Ltd OPT:AU USD 235.28M 87.92M
Pacific Edge PEB:NZ NZD 294.14M 26.44M
Paradigm Biopharmaceuticals Ltd PAR:AU AUD 147.19M 125.8K
Polynovo Ltd PNV:AU AUD 139.43M 180K
PYC Therapeutics Ltd PYC:AU AUD 125.99M 0
Ramsay Health Care RHC:AU AUD 2.2B 0
ResMed RMD:AU USD 586K 1000
Sonic Healthcare SHL:AU AUD 3.87B 277.16M